FactSet Research Systems Inc. has a 52 week low of $391.84 and a 52 week high of $499.87. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 0.65.

Late in 2021 I believed that it was time to look at the facts in the case of FactSet Research (NYSE:FDS). I called the company a continued, stable and secular growth play, yet feared that ...

If you have Original Medicare (parts A and B), you don’t have to worry about filing claims for reimbursement most of the time. However, Medicare Advantage (Part C) and Part D rules are a bit ...

If you’re on the fence about investing in Houlihan Lokey, Inc. or FactSet Research Systems Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

The Department of Justice has reportedly launched a civil fraud investigation into UnitedHealth Group's Medicare billing practices as the company – and the insurance industry as a whole – face ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices ... pandemic-fueled market panic of March 2020, FactSet data shows.

In its fourth quarter 2024 investor letter, Baron Growth Fund emphasized stocks such as FactSet Research Systems Inc. (NYSE:FDS) in the Q4 2024 investor letter. FactSet Research Systems Inc. (NYSE ...

The call will include a live Q&A session. The earnings presentation slides will be available on FactSet’s investor relations website at 10:30 a.m. Eastern Time on March 20, 2025, 30 minutes ...

In Medicare, the term “managed care plans” refers to Medicare Advantage (Part C) plans offered by private companies contracted by Medicare. These plans work in place of your Original Medicare ...

Medicare, by contrast, generally covers those 65 or older. For older Americans with low incomes, Medicaid covers out-of-pocket costs for Medicare. Such people are commonly called "dual eligibles ...